Methods for evaluating the level of biological aging

JP7874857B2Active Publication Date: 2026-06-17NIPPON MENARD COSMETIC CO
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
JP2022085555
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2022-05-25
Publication Date
2026-06-17
Estimated Expiration
2042-05-25

AI Technical Summary

Technical Problem

Existing methods for evaluating biological aging lack objective and accurate indicators that can correlate with the aging process, particularly in assessing brain function, blood aging, and anti-fatigue ability.

Method used

Using the expression levels of Fractalkine, IL-1α, and TNF-α proteins in biological samples such as saliva or blood as indicators to evaluate biological aging, which are correlated with age-related declines in brain function, blood aging, and anti-fatigue ability.

Benefits of technology

Provides an objective and accurate assessment of biological aging, minimizing subject burden through the use of non-invasive samples like saliva or blood, enabling personalized anti-aging interventions and lifestyle adjustments.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007874857000004
    Figure 0007874857000004
  • Figure 0007874857000005
    Figure 0007874857000005
  • Figure 0007874857000006
    Figure 0007874857000006
Patent Text Reader

Abstract

To provide a biological aging level assessment method using an indicator that enables objective and accurate assessment of the biological aging level.SOLUTION: A biological aging level assessment method and an assessment kit are provided, the method using the expression level of one or more proteins selected from Fractalkine, IL-1α, TNF-α, and CD30L in a biological sample as an indicator.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • JP1975021273A

  • Diagnosis, treatment, and prevention of vascular disorders using il-1α autoantibodies

    JP2009503529A

  • Method for evaluating aging degree and kit for evaluating aging degree

    JP2019007759A

  • Methods of diagnosing diseases by extracellular vesicles

    JP2020034560A

  • Agent for inhibiting decrease in neurogenesis

    JP2020063229A